Literature DB >> 12121898

Clindamycin as an antimalarial drug: review of clinical trials.

Bertrand Lell1, Peter G Kremsner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12121898      PMCID： PMC127356          DOI： 10.1128/AAC.46.8.2315-2320.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  65 in total

1.  A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya.

Authors:  J van Dillen; M Custers; A Wensink; B Wouters; T van Voorthuizen; W Voorn; B Khan; L Muller; C Nevill
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Mar-Apr       Impact factor: 2.184

2.  Malaria in Humaita County, State of Amazonas, Brazil. XIX--Evaluation of clindamycin for the treatment of patients with Plasmodium falciparum infection.

Authors:  D A Meira; P C Pereira; J Marcondes-Machado; R P Mendes; B Barraviera; J A Pirola; M R Guimarães; P R Curl; R P Rodrigues
Journal:  Rev Soc Bras Med Trop       Date:  1988 Jul-Sep       Impact factor: 1.581

3.  Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.

Authors:  M Rolfe
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

4.  Clindamycin is effective against Plasmodium falciparum but not against P. vivax in mixed infections.

Authors:  P G Kremsner; G M Zotter; W Graninger; R M Rocha; U Bienzle; H Feldmeier
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

5.  Multiresistant malaria in Brazil cured with low dose clindamycin.

Authors:  P G Kremsner; H Feldmeier; R M Rocha; W Graninger
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1988 Mar-Apr       Impact factor: 1.846

Review 6.  Clostridium difficile: clinical considerations.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

7.  [Treatment of malaria (P. falciparum) with clindamycin. II - Dosage schedule for 5 days].

Authors:  W D Alecrim; B C Albuquerque; M G Alecrim; H Dourado
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1982 Nov-Dec       Impact factor: 1.846

8.  Review of 40 children with imported malaria.

Authors:  A Lynk; R Gold
Journal:  Pediatr Infect Dis J       Date:  1989-11       Impact factor: 2.129

Review 9.  Severe pseudomembranous enterocolitis in a child: case report and literature review.

Authors:  R J Zwiener; W M Belknap; R Quan
Journal:  Pediatr Infect Dis J       Date:  1989-12       Impact factor: 2.129

10.  Clindamycin treatment of falciparum malaria in Brazil.

Authors:  P G Kremsner; G M Zotter; H Feldmeier; W Graninger; R L Westerman; R M Rocha
Journal:  J Antimicrob Chemother       Date:  1989-02       Impact factor: 5.790
View more
  37 in total

1.  Chemistry and biology of macrolide antiparasitic agents.

Authors:  Younjoo Lee; Jun Yong Choi; Hong Fu; Colin Harvey; Sandeep Ravindran; William R Roush; John C Boothroyd; Chaitan Khosla
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

2.  Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.

Authors:  Sunny Oyakhirome; Saadou Issifou; Peter Pongratz; Fortune Barondi; Michael Ramharter; Jürgen F Kun; Michel A Missinou; Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

3.  Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.

Authors:  Erica L Dahl; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

4.  Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.

Authors:  Jing Yuan; Ken Chih-Chien Cheng; Ronald L Johnson; Ruili Huang; Sittiporn Pattaradilokrat; Anna Liu; Rajarshi Guha; David A Fidock; James Inglese; Thomas E Wellems; Christopher P Austin; Xin-zhuan Su
Journal:  Science       Date:  2011-08-05       Impact factor: 47.728

5.  Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.

Authors:  Steffen Borrmann; Ingrid Lundgren; Sunny Oyakhirome; Bénido Impouma; Pierre-Blaise Matsiegui; Ayola A Adegnika; Saadou Issifou; Jürgen F J Kun; David Hutchinson; Jochen Wiesner; Hassan Jomaa; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system.

Authors:  Haona Li; Jianxiong Deng; Zhihua Yue; Yiexiang Zhang; He Sun; Xuequn Ren
Journal:  Eur J Clin Pharmacol       Date:  2016-11-16       Impact factor: 2.953

Review 7.  Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.

Authors:  Charles O Obonyo; Elizabeth A Juma
Journal:  Malar J       Date:  2012-01-04       Impact factor: 2.979

8.  Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.

Authors:  Miguel Lanaspa; Cinta Moraleda; Sónia Machevo; Raquel González; Beatriz Serrano; Eusebio Macete; Pau Cisteró; Alfredo Mayor; David Hutchinson; Peter G Kremsner; Pedro Alonso; Clara Menéndez; Quique Bassat
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

9.  Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.

Authors:  Heather N Damhoff; Robert J Kuhn; Laura P Stadler
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

10.  In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum.

Authors:  M Ramharter; H Noedl; H Winkler; W Graninger; W H Wernsdorfer; P G Kremsner; S Winkler
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.